Amanote Research
Register
Sign In
Follistatin-Like 1 (FSTL1)
Science-Business eXchange
doi 10.1038/scibx.2013.1024
Full Text
Open PDF
Abstract
Available in
full text
Date
September 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Deletion of Fstl1 (Follistatin-Like 1) From the Endocardial/Endothelial Lineage Causes Mitral Valve Disease
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Follistatin-Like 1 Protects Against Hypoxia-Induced Pulmonary Hypertension in Mice
Scientific Reports
Multidisciplinary
Follistatin-Like Protein 1 Sustains Colon Cancer Cell Growth and Survival
Oncotarget
Oncology
FSTL3 (Follistatin-Like 3 (Secreted Glycoprotein))
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
High Circulating Follistatin-Like Protein 1 as a Biomarker of a Metabolically Unhealthy State
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Follistatin-Like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin
Cancer Research
Cancer Research
Oncology
Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart
Circulation
Cardiovascular Medicine
Physiology
Cardiology
The Process-Inducing Activity of Transmembrane Agrin Requires Follistatin-Like Domains
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Genetic Polymorphism Affects the Risk and Prognosis of Renal Cell Carcinoma: Association With Follistatin-Like Protein 1 Expression
Scientific Reports
Multidisciplinary